| 35166264 | A Nationwide Prospective Clinical Trial on Active Surveillance in Patients With Non-intraabdominal Desmoid-type Fibromatosis: The GRAFITI Trial. | Ann Surg | 2023 |
| 37701038 | Combatting the rising costs of cancer drugs; interventions from a university hospital's perspective. | Front Pharmacol | 2023 |
| 37686693 | Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling. | Cancers (Basel) | 2023 |
| 37968696 | Integrative whole-genome and transcriptome analysis of HER2-amplified metastatic breast cancer. | Breast Cancer Res | 2023 |
| 37119048 | Physical symptom burden in patients with desmoid-type fibromatosis and its impact on health-related quality of life and healthcare use. | Cancer Med | 2023 |
| 37452019 | Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival. | NPJ Breast Cancer | 2023 |
| 37246093 | Local treatment in metastatic GIST patients: A multicentre analysis from the Dutch GIST Registry. | Eur J Surg Oncol | 2023 |
| 37400554 | The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies. | Sci Rep | 2023 |
| 37226020 | Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer. | Breast Cancer Res Treat | 2023 |
| 36621142 | Identifying somatic changes in drug transporters using whole genome and transcriptome sequencing data of advanced tumors. | Biomed Pharmacother | 2023 |
| 36900167 | Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting. | Cancers (Basel) | 2023 |
| 36727954 | Health-related Quality of Life of Patients With Non-Intra-abdominal Desmoid-Type Fibromatosis During Active Surveillance: Results of a Prospective Observational Study. | Ann Surg | 2023 |
| 36127572 | Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort. | Cancer Med | 2023 |
| 34560242 | Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Ann Oncol | 2022 |
| 35740642 | Unraveling Desmoid-Type Fibromatosis-Specific Health-Related Quality of Life: Who Is at Risk for Poor Outcomes. | Cancers (Basel) | 2022 |
| 35401025 | Prognostic Significance of Bone Metastasis in Soft Tissue Sarcoma Patients Receiving Palliative Systemic Therapy: An Explorative, Retrospective Pooled Analysis of the EORTC-Soft Tissue and Bone Sarcoma Group (STBSG) Database. | Sarcoma | 2022 |
| 35606463 | Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing. | Br J Cancer | 2022 |
| 35366566 | Validity and utility of HER2/ERBB2 copy number variation assessed in liquid biopsies from breast cancer patients: A systematic review. | Cancer Treat Rev | 2022 |
| 35628441 | <i>ESR1</i> Methylation Measured in Cell-Free DNA to Evaluate Endocrine Resistance in Metastatic Breast Cancer Patients. | Int J Mol Sci | 2022 |
| 35567919 | First-in-man, first-in-class phase I study with the monopolar spindle 1 kinase inhibitor S81694 administered intravenously in adult patients with advanced, metastatic solid tumours. | Eur J Cancer | 2022 |
| 36455584 | Alternative dosing strategies for immune checkpoint inhibitors to improve cost-effectiveness: a special focus on nivolumab and pembrolizumab. | Lancet Oncol | 2022 |
| 36017997 | Physicians' Perspectives on Ethical Issues Regarding Expensive Anti-Cancer Treatments: A Qualitative Study. | AJOB Empir Bioeth | 2022 |
| 36323051 | CABA-V7: a prospective biomarker selected trial of cabazitaxel treatment in AR-V7 positive prostate cancer patients. | Eur J Cancer | 2022 |
| 36077836 | Intratumoral Niches of B Cells and Follicular Helper T Cells, and the Absence of Regulatory T Cells, Associate with Longer Survival in Early-Stage Oral Tongue Cancer Patients. | Cancers (Basel) | 2022 |
| 35158976 | Development of a Disease-Specific Health-Related Quality of Life Questionnaire (DTF-QoL) for Patients with Desmoid-Type Fibromatosis. | Cancers (Basel) | 2022 |
| 35221159 | In desmoid-type fibromatosis cells sorafenib induces ferroptosis and apoptosis, which are enhanced by autophagy inhibition. | Eur J Surg Oncol | 2022 |
| 35248823 | Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer. | ESMO Open | 2022 |
| 35151276 | The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer. | BMC Cancer | 2022 |
| 34878805 | Prognostic Value of Circulating Tumor Cell Characteristics May Be Biased by Their Quantity. | J Clin Oncol | 2022 |
| 35088185 | Differential Diagnosis and Molecular Stratification of Gastrointestinal Stromal Tumors on CT Images Using a Radiomics Approach. | J Digit Imaging | 2022 |
| 34964258 | A pipeline for copy number profiling of single circulating tumour cells to assess intrapatient tumour heterogeneity. | Mol Oncol | 2022 |
| 35050709 | Apolipoprotein B mRNA-Editing Catalytic Polypeptide-Like-Induced Protein Changes in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Throughout Disease Progression. | JCO Precis Oncol | 2022 |
| 32949099 | Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patients. | Mol Oncol | 2021 |
| 33765967 | Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial. | BMC Cancer | 2021 |
| 33514525 | Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases. | Clin Cancer Res | 2021 |
| 33761899 | Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer. | BMC Cancer | 2021 |
| 33643695 | B-cell clusters at the invasive margin associate with longer survival in early-stage oral-tongue cancer patients. | Oncoimmunology | 2021 |
| 33920135 | A Systematic Review of the Use of Circulating Cell-Free DNA Dynamics to Monitor Response to Treatment in Metastatic Breast Cancer Patients. | Cancers (Basel) | 2021 |
| 33915880 | The <i>BRAF</i> P.V600E Mutation Status of Melanoma Lung Metastases Cannot Be Discriminated on Computed Tomography by LIDC Criteria nor Radiomics Using Machine Learning. | J Pers Med | 2021 |
| 33495476 | Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features. | Nat Commun | 2021 |
| 34500044 | Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up. | Ann Oncol | 2021 |
| 34555650 | Adjuvant treatment in patients with melanoma: The planning of scanning. | Eur J Cancer | 2021 |
| 34670587 | High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments. | Clin Epigenetics | 2021 |
| 34781194 | Cost-effectiveness of adjuvant systemic therapies for patients with high-risk melanoma in Europe: a model-based economic evaluation. | ESMO Open | 2021 |
| 34303806 | Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>â¿¿</sup>. | Ann Oncol | 2021 |
| 34326338 | The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets. | Nat Commun | 2021 |
| 34249756 | Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients. | Front Oncol | 2021 |
| 34039979 | Author Correction: Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features. | Nat Commun | 2021 |
| 33932725 | Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells. | Eur J Cancer | 2021 |
| 34206149 | The Evaluation of Health-Related Quality of Life Issues Experienced by Patients with Desmoid-Type Fibromatosis (The QUALIFIED Study)-A Protocol for an International Cohort Study. | Cancers (Basel) | 2021 |